Merck Receives Positive CHMP Opinion for VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) in Infants and ChildrenBusiness Wire • 09/16/22
Goldman Sachs Says Beware of Dangerous Fall Market Volatility: 7 Safe Conviction List Dividend Stocks to Buy Now24/7 Wall Street • 09/14/22
Merck & Co., Inc. (MRK) Presents at Morgan Stanley 20th Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/12/22
Seagen, Astellas and Merck Announce Results of Clinical Trial Investigating PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) and PADCEV as Monotherapy in First-Line Advanced Urothelial CancerBusiness Wire • 09/12/22
Astellas, Seagen and Merck Announce Results of Clinical Trial Investigating PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) and PADCEV as Monotherapy in First-Line Advanced Urothelial CancerPRNewsWire • 09/12/22
Merck Gambled With Keytruda In 2011 — How That Jump Is Still Paying Off TodayInvestors Business Daily • 09/11/22
Five-Year Data for Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy Showed Sustained Survival Benefit Versus Chemotherapy Alone in Two Studies for Metastatic Non-Small Cell Lung Cancer (NSCLC)Business Wire • 09/11/22
Merck and Eisai Present Results From Phase 3 LEAP-002 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Versus LENVIMA Monotherapy in Patients With Unresectable Hepatocellular CarcinomaBusiness Wire • 09/10/22
LYNPARZA® (olaparib) in Combination With Bevacizumab, and as Monotherapy, Demonstrates Clinically Meaningful Long-Term Survival in Certain Patients With First-Line Advanced Ovarian Cancer in Exploratory Analyses of Two Phase 3 TrialsBusiness Wire • 09/09/22
Goldman Sachs Says Next Fed Rate Increases Will Be Big: 7 Conviction List Dividend Stocks to Buy Now24/7 Wall Street • 09/09/22
Merck Foundation Launches $20 Million Initiative to Advance Equity in U.S. Cancer CareBusiness Wire • 09/08/22
Merck to Highlight Data at ESMO 2022 with Potential for Transformative Impact on Cancer PatientsBusiness Wire • 09/07/22
Merck to Present at the Morgan Stanley 20th Annual Global Healthcare ConferenceBusiness Wire • 09/06/22